Prostate cancer remains the most frequently diagnosed cancer in men in North America, and
despite recent advances in treatment patients with metastatic disease continue to have poor …

Simple Summary Prostate cancer is the most common malignancy in men, with a high
mortality rate when disease progresses to metastasis and therapeutic resistance. Evidence …

The inducible nitric oxide signaling (iNOS) pathway is associated with poor prognosis in
triple-negative breast cancer (TNBC). Prior studies using in vivo models showed that …

Patients with metastatic castration-resistant prostate cancer (mCPRC) now have an
unprecedented number of approved treatment options, including chemotherapies …

Prostate cancer (PC) is the second most common form of cancer in men worldwide.
Biomarkers have emerged as essential tools for treatment and assessment since the …

Inflammation has been suggested to play an important role in onset and progression of
prostate cancer (PCa). Histological analysis of prostatectomy specimens has revealed focal …

Chemotherapy has been explored as a treatment option for metastatic prostate cancer since
the early 1980s. Docetaxel, a taxane chemotherapeutic, was approved for the treatment of …

Abstract Introduction Panax notoginseng (Burkill) FH commonly referred to as Sanqi, is a
Chinese herb that has long been used to treat various conditions including blood disorders …

Metastasis causes more than 90% of cancer-related deaths and most prostate cancer (PCa)
patients also die from metastasis. The 'metastatic cascade'is a complex biological process …

Docetaxel (DTX) is used against breast cancer despite its side effects such as toxicity and
immunosuppression. Here we investigated the cytotoxic and immunomodulatory effects of …